Degenerative Disc Disease Treatment Market Size

Degenerative Disc Disease Treatment Market Size

Degenerative Disc Disease Treatment Market size accounted for USD 24 billion in 2022 and is estimated to grow at 7.2% to reach USD 49.7 billion by 2032. Growing prevalence of degenerative bone diseases will positively influence the market growth.

To get key market trends

  Download Free Sample

For instance, in 2021, according to the Centers of Disease Control and Prevention (CDC), adults aged 65 years and above are more affected by degenerative bone disease. The CDC also estimated that nearly 78 million (26%) of U.S. adults aged 18 years or older are projected to have doctor-diagnosed arthritis by 2040. This indicates that there will huge number of patient pool suffering from degenerative bone disease. Such high prevalence of the disease will increase the product demand.

Degenerative disc disease (DDD) is a condition that affects the intervertebral discs in the spine, causing them to degenerate and lose their flexibility over time. Degenerative disc disease (DDD) treatment involves a stepwise approach to manage symptoms. Conservative measures like physical therapy, pain medications, and lifestyle modifications are commonly employed. In some cases, epidural steroid injections may be used to reduce inflammation. Also, surgical interventions like discectomy, spinal fusion, or artificial disc replacement may be considered for severe cases. The choice of treatment depends on symptom severity, disc degeneration, and individual health.